STOCK TITAN

TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX) will release its first-quarter financial results on May 4, 2021, after market close. A conference call will follow at 4:30 p.m. ET for investors to discuss the results. The company specializes in advanced organ transplant technologies aimed at improving donor organ quality and viability assessment for heart, lung, and liver transplants. Investors can access the call by phone or via the live webcast on the company's website.

Positive
  • Leadership in portable extracorporeal warm perfusion for organ transplantation.
  • Technologies aimed at improving organ quality and viability assessments.
Negative
  • None.

ANDOVER, Mass., April 20, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the first quarter after market close on Tuesday, May 4, 2021. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (866) 393-4306 for domestic callers or (763) 488-9145 for international callers, followed by Conference ID: 1172894. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-report-first-quarter-2021-financial-results-on-may-4-2021-301273113.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics report its Q1 2021 financial results?

TransMedics will report its Q1 2021 financial results on May 4, 2021.

What time is the TransMedics Q1 2021 conference call?

The conference call will begin at 4:30 p.m. ET on May 4, 2021.

How can I listen to the TransMedics investor call?

Investors can listen by calling (866) 393-4306 domestically or (763) 488-9145 internationally, or via the live webcast on the TransMedics website.

What is TransMedics' focus within organ transplantation?

TransMedics focuses on portable organ perfusion technologies and improving organ viability for transplantation.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.59B
32.48M
3.18%
111.8%
25.11%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER